Scleroderma News and Research

Latest Scleroderma News and Research

BU researcher receives NIH grant for clinical research in rheumatology

David Felson, MD, MPH, professor of medicine and epidemiology at Boston University Schools of Medicine and Public Health, was awarded a National Institute of Health P30 Center Grant.

15 Oct 2019

Clinical trial to evaluate efficacy and safety of new treatment for giant cell arteritis

An international, multicenter phase II clinical trial is evaluating the efficacy and safety of mavrilimumab co-administered with a 26-week corticosteroid taper in patients with giant cell arteritis.

26 Sep 2019

Survey says half of people with rheumatoid disease struggle to pay for treatment

Rheumatoid disease encompasses inflammatory conditions that affect the joints, muscle, bones, and organs. A new study found that despite 90 of patients have health insurance, nearly 60 percent said that they are struggling to afford medication or treatment in the last year.

16 Sep 2019

Failed cancer drug could potentially be used to treat fibrotic diseases and scleroderma

Sixteen years ago, a research group at Mayo Medical School published results showing that a protein called TRAIL can kill cells that cause liver fibrosis but no one seemed to follow up on these findings.

From Johns Hopkins Medicine 13 Sep 2019

FDA approves first drug to treat patients with rare lung condition

The U.S. Food and Drug Administration today approved Ofev (nintedanib) capsules to slow the rate of decline in pulmonary function in adults with interstitial lung disease associated with systemic sclerosis or scleroderma, called SSc-ILD. It is the first FDA-approved treatment for this rare lung condition.

7 Sep 2019

Elevated estrogen levels associated with more severe disease in scleroderma

Estrogen is the quintessentially female hormone. It is surprising, then, that a Medical University of South Carolina study found that a type of estrogen, estradiol, was more abundant in older men with scleroderma than in postmenopausal women with the disease.

6 Jun 2019

Newly identified internal regulator helps control body's response to fight infection

Scientists have identified a new internal regulator which helps control the body's response to fight infection.

30 May 2019

Finding potential treatments for autoimmune diseases

More than 50 million Americans are affected by an autoimmune disease, with women at an increased risk for developing one.

7 May 2019

Suppressing cancer-causing protein could correct increased fibrosis in scleroderma patients

A protein known to play a role in cancer may also be increasing fibrosis in scleroderma patients.

27 Feb 2019

MUSC researchers identify potential therapeutic target for lung fibrosis

In an article published online by Frontiers in Endocrinology, researchers at the Medical University of South Carolina report that they have identified a potential therapeutic target for lung fibrosis or scarring.

19 Dec 2018

Silicone breast implants may increase risk of rare adverse outcomes in women

Women receiving silicone breast implants may be at increased risk of several rare adverse outcomes compared to the general population, reports a study in Annals of Surgery.

18 Sep 2018

Study shows B cells could play reciprocal roles in pathogenesis of systemic sclerosis

Systemic sclerosis (SSc, also known as scleroderma), a connective tissue disorder of autoimmune etiology, is characterized by excessive fibrosis in the skin and various internal organs.

30 Aug 2018

Scleroderma Foundation names Tulane professor as 'Doctor of the Year'

Dr. Lesley Ann Saketkoo, an associate professor of clinical medicine at Tulane University School of Medicine, has been named Doctor of the Year by the Scleroderma Foundation. The award recognizes leadership and commitment to the community battling scleroderma, a disabling and life-limiting multi-organ autoimmune disease with progressive lung, heart, kidney, gastrointestinal tract and/or vascular involvement.

21 Aug 2018

Seeking solutions to treat scleroderma

It begins with cold hands. Not just put-on-some-gloves cold. Instead, the fingers overreact to cold by turning white or blue and may become numb or tingly.

17 Aug 2018

Researchers find experimental compound to treat fibrotic diseases

Normal scar tissue forms to heal an internal wound and quietly retreats when the job is done. But in many common diseases - kidney, liver and lung fibrosis -- the scar tissue goes rogue and strangles vital organs. These diseases are largely untreatable and ultimately fatal.

13 Jul 2018

Study: Lenabasum has acceptable safety and tolerability in diffuse cutaneous systemic sclerosis

The results of an open label extension of a phase II study presented today at the Annual European Congress of Rheumatology, 2018, demonstrate that lenabasum continues to have acceptable safety and tolerability in diffuse cutaneous systemic sclerosis with no severe or serious adverse events.

18 Jun 2018

Improving the Diagnosis of Cardiac Sarcoidosis

Cardiac sarcoidosis is an inflammatory disease of the heart that results in various clinical manifestations. Dr Nadera Sweiss discusses her research in the field of sarcoidosis and how diet can influence the diagnosis of the condition.

30 Apr 2018

Study uncovers mechanism causing chronic GVHD after bone marrow transplant

Allogeneic bone marrow transplant (BMT) is an essential treatment to cure patients with blood cancers such as leukemia. In patients who have undergone chemotherapy and radiation, a small number of cancer cells can remain in the bloodstream and allow the malignancy to recur.

3 Apr 2018

Report highlights needs, experiences of people with rare autoimmune rheumatic diseases

People living with rare autoimmune rheumatic diseases are facing major obstacles to diagnosis, treatment and lifestyle according to a major new study published today [Wednesday 28th February].

28 Feb 2018

ACR receives grant to focus on projects that reduce health disparities

The American College of Rheumatology's new program, Uniting Collaborators for Innovation, was named one of five recipients of the American Society of Association Executives Foundation Innovation Grants Program, which awards $10,000 to programs that demonstrate engagement in innovation efforts within the association community. UCOIN is being developed by the ACR's Collaborative Initiatives department as a platform for member-led projects that reduce health disparities.

14 Feb 2018

Scleroderma News and Research

Latest Scleroderma News and Research

BU researcher receives NIH grant for clinical research in rheumatology

Clinical trial to evaluate efficacy and safety of new treatment for giant cell arteritis

Survey says half of people with rheumatoid disease struggle to pay for treatment

Failed cancer drug could potentially be used to treat fibrotic diseases and scleroderma

FDA approves first drug to treat patients with rare lung condition

Elevated estrogen levels associated with more severe disease in scleroderma

Newly identified internal regulator helps control body's response to fight infection

Finding potential treatments for autoimmune diseases

Suppressing cancer-causing protein could correct increased fibrosis in scleroderma patients

MUSC researchers identify potential therapeutic target for lung fibrosis

Silicone breast implants may increase risk of rare adverse outcomes in women

Study shows B cells could play reciprocal roles in pathogenesis of systemic sclerosis

Scleroderma Foundation names Tulane professor as 'Doctor of the Year'

Seeking solutions to treat scleroderma

Researchers find experimental compound to treat fibrotic diseases

Study: Lenabasum has acceptable safety and tolerability in diffuse cutaneous systemic sclerosis

Improving the Diagnosis of Cardiac Sarcoidosis

Study uncovers mechanism causing chronic GVHD after bone marrow transplant

Report highlights needs, experiences of people with rare autoimmune rheumatic diseases

ACR receives grant to focus on projects that reduce health disparities

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Scleroderma News and Research

Latest Scleroderma News and Research

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in